| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.64 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.49 | 0.0003 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.42 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.38 | 0.003 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.35 | 0.05 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.34 | 0.05 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |